Track record
Chris Wolfe
An officer, director or large holder of 4 blank-check companies. Every role below was declared by Chris Wolfe in an SEC ownership filing.
Vehicles
4
Still live
0
Closed a deal
3 of 4
Capital involved
$578M
Every vehicle, newest first
- DA32 Life Science Tech Acquisition Corp.— · Chief Financial Officer · IPO Jul 29, 2021$204MLiquidated
- CareMax, Inc.— · Chief Financial Officer · IPO Jul 20, 2020$144MCompleted
- Starling Oncology, Inc.STLN · Chief Financial Officer · IPO Mar 12, 2020$230MCompleted
- AdaptHealth Corp.AHCO · Chief Financial Officer · IPO Feb 15, 2018Completed
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1472624. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.